Literature DB >> 2465188

Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.

G Wallin1, M Bäckdahl, E Tallroth-Ekman, G Lundell, G Auer, T Löwhagen.   

Abstract

Clonal transformation of well differentiated follicular or papillary carcinomas has been suggested as a mechanism by which anaplastic carcinomas of the thyroid might arise. Of 126 cases of anaplastic (giant cell) carcinomas, 17 (13.5%) contained histologically well differentiated tumour foci within or adjacent to the high grade malignant anaplastic tumour. Cytophotometric DNA analysis after Feulgen staining was performed on 11 cases in order to evaluate ploidy of the anaplastic and the well differentiated tumour cells. The majority of these co-existent carcinomas (9/11) were papillary. All 11 anaplastic carcinomas demonstrated an aneuploid DNA pattern which correlated with a poor clinical outcome (7 of 11 died of disease in less than 6 months). In contrast six co-existent papillary and one co-existent follicular tumours were diploid. These data show that the co-existence of anaplastic and well differentiated carcinoma occurs only rarely and when it occurs only one third of the well differentiated tumours contain aneuploid tumour cells. This suggests that in the majority of cases of anaplastic thyroid carcinoma the malignant cells arise de novo rather than through clonal transformation of well differentiated carcinomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465188

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data.

Authors:  Tam N M Ngo; Trang T B Le; Thoa Le; Andrey Bychkov; Naoki Oishi; Chan Kwon Jung; Lewis Hassell; Kennichi Kakudo; Huy Gia Vuong
Journal:  Endocr Pathol       Date:  2021-09-24       Impact factor: 3.943

3.  Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.

Authors:  Anne-Birgitte Jacobsen; Krystyna K Grøholt; Bianca Lorntzsen; Terje A Osnes; Ragnhild Sørum Falk; Eva Sigstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-10       Impact factor: 2.503

4.  Anaplastic Thyroid Cancer: Experience of the Philippine General Hospital.

Authors:  Tom Edward Lo; Cecilia Alegado Jimeno; Elizabeth Paz-Pacheco
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-29

Review 5.  Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?

Authors:  Marco Volante; Alfred K Lam; Mauro Papotti; Giovanni Tallini
Journal:  Endocr Pathol       Date:  2021-02-04       Impact factor: 3.943

6.  Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?

Authors:  Carl Christofer Juhlin
Journal:  Cancer Drug Resist       Date:  2020-11-03

7.  Risk Factors for Anaplastic Thyroid Carcinoma: A Case Series From a Tertiary Referral Center for Thyroid Surgery and Literature Analysis.

Authors:  Giuseppa Graceffa; Giuseppe Salamone; Silvia Contino; Federica Saputo; Alessandro Corigliano; Giuseppina Melfa; Maria Pia Proclamà; Pierina Richiusa; Sergio Mazzola; Roberta Tutino; Giuseppina Orlando; Gregorio Scerrino
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

8.  Risk factors for anaplastic thyroid cancer.

Authors:  V Zivaljevic; N Slijepcevic; I Paunovic; A Diklic; N Kalezic; J Marinkovic; R Zivic; B Vekic; S Sipetic
Journal:  Int J Endocrinol       Date:  2014-05-18       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.